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Abstract  14 
Intestinal macrophages are the largest group of mononuclear phagocytes in the 15 
body and play a role in intestinal innate immunity, neuroimmune interactions and 16 
maintaining intestinal homeostasis.  Conversely, they also are implicated in 17 
numerous pathologies of the gastrointestinal tract, such as postoperative ileus and 18 
inflammatory bowel disease. As a result, macrophages could be potential 19 
therapeutic targets. To date, there are limited studies on the morphology and 20 




this study was to identify the location and abundance of resident macrophages in 22 
the equine GIT using CD163 as an immunohistochemical marker. Tissue samples 23 
were obtained post-mortem from 14 sites along the gastrointestinal tracts of 10 24 
horses free from gastrointestinal disease; sample sites extended from the stomach 25 
to the small colon.  CD163+ve cells were present in all regions of the equine GIT 26 
from stomach to small colon.  CD163+ve cells were also identified in all tissue 27 
layers of the intestinal wall; namely, mucosa, submucosa, muscularis externa 28 
(ME), myenteric plexus and serosa.  Consistent with a proposed function in 29 
regulation of intestinal motility, CD163+ve cells were regularly distributed within 30 
the ME, with accumulations closely associated with the myenteric plexus and 31 
effector cells such as neurons and the interstitial cells of Cajal (ICC).  32 
Keywords: horse; CD163; macrophage; gastrointestinal tract; intestine; 33 
inflammation 34 
Abbreviations 35 
BMP bone morphogenetic protein 36 
GIT Gastrointestinal tract 37 
ICC Interstitial cells of Cajal 38 
LpM Lamina propria macrophages 39 
ME muscularis externa 40 
MM muscularis macrophages 41 
MP myenteric plexus 42 





Resident tissue macrophages are abundant in every organ and adapt in each 45 
location to perform tissue-specific roles.  Resident intestinal macrophages are a 46 
good example of this heterogeneity.  They are suitably adapted to maintain 47 
intestinal mucosal homeostasis, in addition to playing a role in infection and 48 
inflammation within what is considered a unique and difficult environment due to 49 
constant antigenic challenge from intestinal luminal contents.  It is therefore 50 
unsurprising that the gastrointestinal tract (GIT) represents the largest reservoir of 51 
macrophages in the body (Lee et al., 1985).  Intestinal macrophages are divided 52 
into two distinct sub-populations: lamina propria or mucosal macrophages (LpM) 53 
and muscularis macrophages (MM).  Their survival is dependent upon signals 54 
from the macrophage colony-stimulating factor receptor (CSF1R), and in mice 55 
they are rapidly depleted by treatment with anti-CSF1R antibody (MacDonald et 56 
al., 2010).  Intestinal macrophages, like most tissue macrophages, are derived 57 
from precursors from the yolk sac or fetal liver.   However, LpM were shown to 58 
turn over relatively rapidly with replacement from blood monocytes in both 59 
mouse (Bain et al., 2014) and humans (Bujko et al., 2018).  In comparison to 60 
LpM, MM have a slower turnover rate  and are long-lived (Mikkelsen et al., 2004) 61 
although more recent studies in mice suggest the presence of a longer-lived sub-62 
population of LpM defined by expression of the surface markers CD4 and TIM4 63 
(Shaw et al., 2018).  Long-lived MM are both embryonic and monocyte-derived 64 
with a lower turnover than LpM (De Schepper et al., 2018). 65 
The abundant LpM population in mice and humans are CD64+ve, MHC Class IIhi, 66 
CD206+ve and CD163+ve.  Additionally, in mice LpM are CD11b+ve, CD11c+ve, 67 




levels of these markers but instead express CD209 (Bain and Schridde, 2018).   69 
LpM are highly phagocytic and bactericidal but exist in a state of ‘hypo-70 
responsiveness’.  This anergy can be attributed to the absence of the 71 
lipopolysaccharide (LPS) receptor CD14 and the failure of LpM to produce 72 
proinflammatory cytokines like tumour necrosis factor-α (TNFα) (Smythies et al., 73 
2005).  In pigs, genes for C-type lectins including CLEC7A, CD68 and SIGLEC1 74 
were down regulated in the GIT when compared to alveolar macrophages again 75 
supporting the expectation that intestinal macrophages tend to be hypo-responsive 76 
(Freeman et al., 2012).  Additionally, macrophage production and sensing of the 77 
anti-inflammatory cytokine interleukin 10 (IL10) is essential to maintain intestinal 78 
homeostasis with rodents that are IL10 deficient developing severe colitis 79 
(Zigmond et al., 2014).  The position of LpM under the epithelium enables them 80 
to be ideally situated to sample luminal contents, such as bacteria or dietary 81 
antigens, using transepithelial dendrites (Niess et al., 2005).  Depletion of LpM 82 
with anti-CSF1R antibody revealed an essential function in the control of 83 
proliferation and differentiation of intestinal epithelial cells by CD169 expressing 84 
cells (Sehgal et al., 2018).   85 
MM are considered a phenotypically distinct group from LpM (Gabanyi et al., 86 
2016; Muller et al., 2014) but do express CD64, MHC Class II, CD206 and 87 
CD163 as LpM do (Bain and Schridde, 2018).  In contrast to LpM, MM express 88 
the LPS receptor CD14, meaning they can play a role in endotoxin-mediated 89 
responses within the muscularis (Kalff et al., 1998b).  Whilst their role in the 90 
intestine has not been as extensively studied as the LpM population, rodent 91 
derived data show that MM interact with neurons to control intestinal motility.  92 




receptor on enteric neurons. Enteric neurons produce CSF1, maintaining the MM 94 
population.  This bi-directional interaction regulates the smooth muscle 95 
contractions of peristalsis (Muller et al., 2014).  Although MM appear in the 96 
intestinal wall during embryonic development, their development in mice is 97 
unaffected by the absence of an enteric nervous system (Avetisyan et al., 2018). 98 
Human and rodent studies have described intestinal macrophages in all cross-99 
sectional regions of the intestine with a variation in their morphology dependent 100 
upon their location.  In the mouse, serosal macrophages are bipolar, slender, 101 
orientated parallel to the longitudinal muscle and occasionally have bifurcated 102 
processes (Mikkelsen, 2010).  Cells within the circular and longitudinal muscle 103 
layers are found between the muscular bundles and have an elongated thin shape, 104 
with those in the longitudinal muscle being less elongated compared with those 105 
within the circular muscle (Kalff et al., 1998b).  Their location, morphology and 106 
CSF1 responsiveness can be visualised using Csf1r reporter transgenes in mice 107 
and rats (Hawley et al., 2018; Irvine et al., 2020; Sauter et al., 2014). 108 
Macrophages between the circular and longitudinal muscle layers, at the level of 109 
the MP (also termed Auerbach’s Plexus) are stellate with multiple dendrites (Kalff 110 
et al., 1998b; Mikkelsen, 2010).  111 
Dysregulation or activation of intestinal macrophages contributes to the 112 
pathogenesis of inflammatory bowel disease and postoperative ileus (POI) (Kalff 113 
et al., 1998a; Na et al., 2019).  In mice, recruited monocytes contribute to the 114 
resolution of POI and the administration of CSF1, has therapeutic potential (Farro 115 
et al., 2017).  POI in horses is a life-threatening complication of abdominal 116 




macrophages in the pathogenesis of POI in other species, there have been few 118 
studies in the horse.  119 
Studies on the  distribution of macrophages in the equine GIT are limited, as is the 120 
number of species-specific reagents available.  This may be partly attributable to 121 
limited availability of appropriate immunological markers, such as F4/80 which is 122 
commonly used in mice (Hume et al., 1984).  A common surface marker used in 123 
multiple species, including the horse, is the macrophage scavenger receptor for 124 
the haemoglobin-haptoglobin complex (CD163) which distinguishes resident 125 
macrophages from recently-recruited monocytes (Chapuy et al., 2019; Sauter et 126 
al., 2016; Van den Heuvel et al., 1999; Yamate et al., 2000).  Previously used 127 
markers for macrophage identification in the horse include the following; CD163 128 
to identify laminar, intestinal (mucosal), uveal and alveolar macrophages  129 
(Faleiros et al., 2011; Grosche, 2011; Karagianni et al., 2013; Sano et al., 2016; 130 
Yamate et al., 2000), CD68 in monocyte-derived macrophages (MDM) and 131 
various tissue macrophages including the small intestine (Fidalgo-Carvalho et al., 132 
2009; Siedek et al., 2000), MHC Class II in MDM and uveal macrophages 133 
(Fidalgo-Carvalho et al., 2009; Sano et al., 2016), CD14 in monocytes, tendons, 134 
alveolar and peritoneal macrophages  (Chelvarajan et al., 2015; Dakin et al., 2012; 135 
Karagianni et al., 2013), CD172a (Sirpα) in tendon macrophages (Dakin et al., 136 
2012), TLR4 in alveolar, peritoneal and pulmonary macrophages (Karagianni et 137 
al., 2013; Singh Suri et al., 2006), CD206 in tendon macrophages (Dakin et al., 138 
2012), MAC387 (MRP-8 and MRP-14) in intestinal (mucosal) macrophages 139 
(Packer et al., 2005; Steuer et al., 2018) and lysozyme in mucosal macrophages 140 
(Packer et al., 2005) although both MAC387 and lysozyme are non-specific for 141 




Significant species-specific responses exist in macrophages.  For example, in 143 
response to LPS equine bone marrow-derived macrophages do not produce nitric 144 
oxide unlike rodents which do (Young et al., 2018).  Several studies have 145 
highlighted that the horse immune response is more similar to that of human than 146 
mouse (Karagianni et al., 2017; Parkinson et al., 2017).  Additionally, sequence 147 
analysis of human, rodent and horse genes involved in immunity have 148 
demonstrated greater synteny between horse and human than rodent and human 149 
(Hudgens et al., 2011; Tompkins et al., 2010).  The significant role in immunity 150 
that macrophages play, and the reported differences in macrophage responses that 151 
occur between species, highlights the importance of studying the cells of interest 152 
in each species and not always relying on existing data derived from other species 153 
(usually rodents).  In the GIT, CD163 has been used as a marker to identify both 154 
resident and inflammatory equine intestinal macrophages (Grosche et al., 2011; 155 
Nielsen et al., 2015; Yamate et al., 2000).  The context of the former study 156 
focussed on changes in macrophages in the mucosa in response to inflammation 157 
and the latter focused on the demonstration of cross-reactivity of a specific anti-158 
CD163 antibody (clone AM-3K) between various species (humans, dogs, cats, 159 
cattle, pigs and rabbits) and no quantitation was attempted.  In this present study 160 
we examine the distribution of CD163+ve resident macrophages in the normal 161 
equine GIT by immunohistochemistry using an anti-CD163 (Clone EdHu-1) 162 
monoclonal antibody (mAb).  This will form a baseline for future studies of 163 
macrophage populations within the normal equine GIT and help to improve our 164 






Ten horses (median age 17 years, range 6 - 26 years) of various breeds, were 168 
admitted to the Equine Hospital at the Royal (Dick) School of Veterinary Studies 169 
for elective euthanasia (Table 1).  Horses were euthanased with secobarbital 170 
sodium 400mg/ml and cinchocaine hydrochloride 25mg/ml (SomuloseTM; 171 
Arnolds/Dechra), at a dose of 1ml/10kg bodyweight via a pre-placed intravenous 172 
catheter in the left jugular vein.  None of the animals had any chronic or recent 173 
history of gastrointestinal (GI) disease and post -mortem examination confirmed 174 
the absence of any gross GI pathology.  The study was approved by the University 175 
of Edinburgh School of Veterinary Medicine Ethical Review Committee.  176 
Collection of samples from the gastrointestinal tract 177 
Following euthanasia, an incision was made in the ventral midline to expose the 178 
abdominal cavity.  The GIT was removed from the body by transecting the 179 
oesophagus at the level of the diaphragm, removing the mesenteric and body wall 180 
attachments and transecting the small colon at the junction with the rectum.  181 
Spleen and liver were removed, and the GIT placed on a clean working area.  182 
Gross contamination of blood was removed with water.  Full thickness 4 cm x 4 183 
cm sections were removed from 14 anatomical locations from the stomach to the 184 
small colon (Table 2) and rinsed in cold phosphate-buffered saline (PBS) 185 
(Dulbecco’s Phosphate Buffered Saline; Sigma-Aldrich) prior to being trimmed 186 
into smaller segments and placed in 10% neutral buffered formalin (4% 187 
formaldehyde in neutral buffered solution) (Sigma-Aldrich).  Sites were selected 188 




equine GIT and consistently selected from the same region. Areas with 190 
immunological activity, such as Peyer’s Patches were specifically not selected.  191 
Formalin fixed tissue paraffin embedding 192 
Tissue samples were fixed in formalin for 24-72 hours and processed overnight 193 
using an Excelsior tissue processor (Thermo Fisher Scientific), placed in moulds 194 
and embedded in paraffin wax.  Sections five-micron (5 µm) in thickness were 195 
cut, mounted on slides (Superfrost Plus, Thermo Fisher Scientific), air dried for 1 196 
hour and incubated at 550 C for a further hour.  197 
Immunohistochemistry 198 
We elected to use the mouse anti-human mAb (Clone EDHu-1) as previous work 199 
confirmed cross reactivity to both pig (Chen et al., 2019) and cattle (Fry et al., 200 
2016).  Additional studies within our group demonstrated specific cell surface 201 
staining on equine alveolar macrophages, but not on equine bone marrow-derived 202 
macrophages by flow cytometry.  These findings at protein level were as 203 
expected, as indicated by mRNA-Seq analysis (data not shown).  After paraffin 204 
embedding, tissue sections were deparaffinised in xylene and rehydrated in a 205 
graded ethanol series using an automated processor (Leica Autostainer; Leica 206 
Biosystems).  As a routine, all sections were stained with haematoxylin and eosin 207 
(H&E) to allow subsequent confirmation of the absence of any histopathological 208 
change indicative of pre-existing underlying pathology.  Additionally, heat-209 
mediated antigen retrieval was performed on duplicate sections by placing slides 210 
in 0.01M sodium citrate buffer (pH 6.0) in a microwaveable pressure cooker at 211 
approximately 110o C for 20 minutes. Endogenous peroxidase activity was 212 
inhibited using 3% hydrogen peroxide (Peroxidase-blocking solution; Dako 213 




(RT).  Slides were incubated with 100-200 µl blocking buffer (1% normal goat 215 
serum [NGS]; Abcam, 5% bovine serum albumin (BSA); Sigma in tris-buffered 216 
saline [50 mM Tris-Cl, pH 7.6; Sigma, 150 mM NaCl; Sigma, TBS; Abcam]) for 217 
30 minutes at RT in a humidity chamber.  Primary antibody (Mouse anti-human 218 
CD163 Clone EDHu1; Bio-Rad) at a dilution of 1:200 in blocking serum was 219 
applied and slides incubated for 2 hours at RT in a humidity chamber followed by 220 
washing with blocking buffer.  Secondary anti-mouse antibody was applied 221 
(ImmPRESS HRP Anti-Mouse Ig [peroxidase] Polymer Detection Kit; Vector 222 
Labs) for 15-30 minutes at RT, followed by 3,3'-diaminobenzidine (DAB) (3-223 
solution DAB kit; Vector Labs) for 10 minutes.  Slides were either dehydrated and 224 
mounted with no counterstain or counterstained with haematoxylin.  Once dried, 225 
slides were scanned using a Nanozoomer (Hamamatsu Photonics) and analysed 226 
using NDP.view2 (Hamamatsu Photonics).   227 
Quantification of cells in the equine gastrointestinal tract  228 
Tissue sections were visualised using NDP.view2 (Hamamatsu Photonics). Tissue 229 
layers were divided into the following categories; a) mucosa which included the 230 
epithelium, lamina propria and muscularis mucosae (if present) b) submucosa, c) 231 
muscularis externa which included both the inner (circular) and outer 232 
(longitudinal) muscle, d) myenteric plexus (MP) and e)  the serosa. Three areas 233 
within a 2 mm region were selected for counting for each layer; 2 mm from the 234 
left side edge, the mid-point and 2 mm from the right-side edge of the tissue 235 
section.  Areas to be analysed were drawn using either the rectangle or freehand 236 
region function.  All areas were inspected visually prior to counting to evaluate if 237 
sections were representative. If areas were selected that were not representative of 238 




occupying structures e.g. blood vessels was not performed as this could lead to 240 
bias of selecting areas with higher levels of positive staining.  For the mucosa, 241 
submucosa and muscle layers, a 0.5 mm2 area was measured.  For the MP and 242 
serosa, a 0.1 mm2 area was measured. Values were either multiplied by 2 or 10 243 
respectively, to give values per mm2.  Cells were marked manually, counted and 244 
three values for each area averaged for further analysis.  See Supplementary 245 
Figure 1 for a summary of the quantification method. 246 
Statistical analysis 247 
Statistical analysis was performed using GraphPad Prism 8.4.0 for Windows 248 
(GraphPad Software) and significance was assumed at p < 0.05. Significance in 249 
CD163 staining for each tissue layer between individual regions was determined 250 
by a Wilcoxon Signed Rank Test.  Significance in CD163 staining in the different 251 
layers between grouped regions (small intestine vs large intestine) was determined 252 
using a Mann–Whitney U test.  All graphs were created using GraphPad Prism 253 
8.4.0 for Windows (GraphPad Software).  254 
Results 255 
Presence of macrophages in the equine GIT 256 
Sections from 14 regions of equine GIT collected from 10 horses were stained for 257 
CD163.  CD163+ve cells were identified in all intestinal layers (mucosa, 258 
submucosa, muscularis and serosa) and in all regions of the GIT (stomach to 259 




Quantification of macrophages in the equine GIT 261 
The distribution of cells across tissue layers was not uniform. Figure 1 shows the 262 
number of CD163+ve macrophages per mm2 of tissue in all layers and regions of 263 
the equine GIT.    In the distal GIT, from the ileum to the small colon, the highest 264 
density of CD163+ve cells were predominantly in the submucosa.  No clear trend 265 
was observed from the stomach to the distal jejunum.  CD163+ve cells were less 266 
prevalent, but evenly distributed in the muscularis externa throughout the full 267 
length of the GIT.   In the submucosa there was a significant difference (p≤ 268 
0.0001) in CD163+ve cells per mm2 between the small intestine and large intestine 269 
(Figure 2).    A significant increase in positive cells per mm2 was observed 270 
between the distal jejunum to the ileum (p≤0.01) and between the distal jejunum 271 
and the remainder of the sections of the distal GIT (Supplementary Figure 2).  272 
By contrast, the density of CD163+ve cells in the mucosa was relatively consistent 273 
from stomach to small colon.  However, as previously noted in humans and dogs 274 
(Hume et al., 1987; Wagner et al., 2018), CD163+ve macrophages in the colonic  275 
mucosa were notably concentrated towards the apical regions of villi (Figure 3c).    276 
Morphology of macrophages in the equine GIT 277 
Morphological staining characteristics at each location within the GIT are detailed 278 
below: 279 
Mucosa 280 
 CD163+ve cells throughout the GIT were predominantly bipolar, each with two to 281 
three processes and were located entirely beneath the basement membrane within 282 
the lamina propria.  No cells or processes were observed crossing the basement 283 





CD163+ve macrophages were present in the submucosa of all tissue sections in the 286 
small (Figure 5) and large intestine (Figure 6).  In the small intestine, 287 
submucosal macrophages were a mix of round and bipolar cells (Figure 5); whilst 288 
in the large intestine, they were found to be predominantly round (Figure 6).  289 
Macrophages were also observed adjacent to gut-associated lymphoid tissue 290 
(Figure 7).  291 
Muscularis externa, myenteric plexus and serosa 292 
CD163+ve equine macrophages were present in the four areas; the serosa, within 293 
the longitudinal (outer) muscle, at the level of the MP and within the circular 294 
(inner) muscle (Figure 8).  Equine serosal macrophages were relatively regular in 295 
their distribution (Figure 9).  As sections were examined in cross section only, 296 
most macrophages appeared bipolar and it was not possible to visualise whether 297 
cells were ramified in this view, although occasional ramified cells were observed 298 
(Figure 10).   299 
Equine CD163+ve macrophages were found within the muscularis, predominantly 300 
lying between intermuscular bundles (Figure 11).  These cells were uniformly 301 
distributed and aligned parallel with the muscle fibres (Figure 12).  Most cells 302 
appeared bipolar or were identified by single areas of circular positive staining, 303 
attributable to the orientation of the cross sections (Figure 13).   304 
Equine CD163+ve macrophages were observed in close proximity to the MP 305 
(Figure 8), predominantly on the periphery of the MP, although some were also 306 
observed in the centre (Figure 14).  Positively stained cells were bipolar and 307 




mm2) was significantly greater(p≤0.0001) adjacent to the MP compared to that 309 
observed within the  circular and longitudinal muscle either side of the MP in both 310 
the small and large intestine  (Figure 16).  311 
Discussion 312 
This study aimed to identify and provide an overview of the distribution of 313 
macrophages in the normal equine GIT, with a focus on the resident MMs.  The 314 
densities and morphologies of cells labelled with anti-CD163 are broadly similar 315 
to reports of resident macrophages in other species using both CD163 and other 316 
markers.  In the colon of mice, once Ly6C+ve monocytes enter tissues, they 317 
undergo a differentiation process which involves the loss of Ly6C expression and 318 
upregulation of F4/80, CX3CR1, CD163, CD11c and MHC Class II.  Similarly, in 319 
humans, the differentiation of CD14+ve monocytes into intestinal macrophages 320 
involves the down-regulation of CD14 and upregulation of MHC Class II and 321 
CD163 (Bain et al., 2013).  The expression of CD163 on human monocytes and 322 
macrophages is regulated by both pro- and anti-inflammatory signals.  Pro-323 
inflammatory mediators, such as LPS, TNFα and IFN-, suppress CD163 324 
expression; whereas, anti-inflammatory signals, such as IL-10, upregulate CD163 325 
expression (Buechler et al., 2000).  Equine monocytes also express CD163 326 
(Steinbach et al., 2005), as do equine alveolar and peritoneal macrophages 327 
(Karagianni et al., 2013).  Our data supports the view that CD163 is expressed by 328 
populations of resident intestinal macrophages, regardless of their location in the 329 
equine GIT.  CD163 plays an important role in gastrointestinal homeostasis in its 330 
function as a receptor for the haemoglobin-haptoglobin complex, immune sensing 331 




feedback loop (Fabriek et al., 2009; Moestrup and Moller, 2004).  Therefore, the 333 
GIT of the horse is populated with resident intestinal macrophages with an anti-334 
inflammatory phenotype in the steady state.  335 
As previously reported in humans and rodents, all macrophages within the mucosa 336 
were observed in accumulations below the epithelial layer within the lamina 337 
propria (Hume et al., 1983; Nagashima et al., 1996).  Other studies  have shown 338 
CX3CR1+ve cells to sample luminal contents via processes extending through the 339 
basement membrane, between epithelial cells into the lumen in mice (Niess et al., 340 
2005) and in dogs CD163+ve cells have been shown to have transepithelial 341 
cytoplasmic processes (Wagner et al., 2018).  No CD163+ve cells were observed to 342 
cross the basement membrane and epithelial layer in the current study.  We cannot 343 
eliminate the possibility that there are also CD163-ve macrophages in the equine 344 
GIT nor can we assess whether the macrophages in the various locations display 345 
the same level of heterogeneity demonstrated in other species.  This highlights the 346 
potential value of a multi-marker approach to identify of intestinal macrophage 347 
subsets.  Despite the failure to identify processes crossing the epithelial layer, it is 348 
feasible that the marker selected failed to identify a subset of CD163-ve 349 
macrophages.  Attempts to identify such a population, for example via the 350 
detection of MHC Class II expression would be an appropriate future objective.  351 
This could help to identify CD163+ve MHC Class II+ve macrophage populations 352 
and CD163-ve MHC Class II+ve dendritic cell population in the equine GIT.  353 
In the submucosa, a significant increase in cells per mm2 was observed from the 354 
distal jejunum to the ileum and this trend remained consistent for the remainder of 355 
the GIT.  The increase in submucosal macrophages may reflect the change in 356 




– 103 cfu/ml in the stomach to 1011-1012 cfu/ml in the colon (O'Hara and 358 
Shanahan, 2006).  Likewise, an accumulation of CD163+ve cells was observed to 359 
accumulate in the apical regions of the villi and not in the crypts, which may also 360 
reflect the higher antigenic load at the apex of the villus compared to the crypt. 361 
This pattern of expression has also been observed in the dog (Wagner et al., 362 
2018). 363 
Submucosal macrophages are thought to be a self-maintaining population of 364 
macrophages which help to support the submucosal vasculature and enteric 365 
neurons of the submucosal plexus (De Schepper et al., 2018). Although these cells 366 
reside distant to luminal signals, depletion of the submucosal macrophages results 367 
in abnormalities in the submucosal blood supply, suggesting they may play a 368 
stabilising and protective role in remodelling the submucosal vasculature in 369 
response to immune cells in the lamina propria. 370 
As previously reported in humans (Kalff et al., 2003), equine CD163+ve 371 
macrophages were found within the ME, predominantly lying between 372 
intermuscular bundles.  In rodent wholemounts, macrophages can be seen 373 
regularly and uniformly distributed throughout the ME with no overlap of 374 
processes (Mikkelsen et al., 2011; Phillips and Powley, 2012).  In equine tissue, 375 
the MM were predominantly bipolar but only the occasional CD163+ve cell was 376 
observed.  This apparent interspecies difference may be attributable to the 377 
relatively greater thickness of the equine ME and the associated difficulty in 378 
visualising the full network of cells within a single 5µm section.  In comparison, it 379 
would be possible using light microscopy, to examine the full thickness of the 380 




Between the two muscle layers (circular and longitudinal) lies the MP. The MP 382 
forms part of the enteric nervous system which is involved in the control of motor 383 
function, blood flow and modulates immune and endocrine functions in the 384 
intestine.  In rodents, the close proximity of macrophages to the MP has been 385 
clearly documented (Mikkelsen, 2010; Phillips and Powley, 2012), and the 386 
functional importance of this co-localisation has been demonstrated.  In mice, 387 
MM regulate GI motility via the production of BMP2 that acts on enteric neurons; 388 
in addition this neuro-immune communication between the enteric neurons and 389 
MM also stimulates tissue protective responses  (Gabanyi et al., 2016; Muller et 390 
al., 2014).  Equine CD163+ve macrophages were also observed near to the MP 391 
with macrophage density (cells per mm2) greater adjacent to the MP compared to 392 
within the surrounding muscle.  Interstitial cells of Cajal (ICC) are also present in 393 
the MP of the equine GIT and form a network of cells closely associated to the 394 
smooth muscle of the intestine (Hudson et al., 1999), and are considered 395 
pacemakers and mediators of neurotransmission of the GIT (Burns et al., 1996).  396 
As with the neurons, macrophages in close proximity to the ICC may suggest a 397 
functional relationship between them in horses as has been demonstrated in 398 
rodents 399 
The classification of macrophages into M1 (classical) or M2 (alternative) is 400 
widely recognised as an oversimplification of the spectrum of macrophage 401 
phenotypes (Hume, 2015).  However, proposed M2 markers such as CD163 and 402 
CD206 are considered to contribute to an overall anti-inflammatory phenotype 403 
and CD206+ve cells are thought to contribute to resolution of inflammation in 404 
inflammatory bowel disease in humans (Vos et al., 2012).  In humans and rodents 405 




expression of the LPS receptor CD14; MM express higher levels than LpM 407 
(Bujko et al., 2018). The activation of CD14+ve MM, such as occurs in surgical 408 
manipulation of the intestine results in the development of POI (Kalff et al., 409 
1998a).  Intestinal CD14+ve cells contribute to the pathogenesis of Crohns disease 410 
in humans (Kamada et al., 2008).  These examples of other macrophage markers, 411 
that have been previously used in the horse highlight the potential benefits of 412 
further studying macrophage subsets in the horse. Ultimately it will further our 413 
understanding of the induction and resolution of inflammation in the GIT of the 414 
horse and help identify future therapeutic targets. 415 
Conclusion 416 
CD163+ve cells were present in all tissue layers of the equine intestine: mucosa, 417 
submucosa, ME and the serosa. CD163+ve cells were regularly distributed within 418 
the ME, with accumulations adjacent to the MP, and therefore to intestinal 419 
motility effector cells such as neurons and the ICC, supporting a potential 420 
influential role of macrophages on intestinal motility.  Macrophages are not only 421 
involved in the regulation of intestinal homeostasis but are implicated in many 422 
pathologies of the GIT such as POI and inflammatory bowel disease.  Future 423 
studies aimed at investigating whether POI or other diseases associated with 424 
intestinal dysmotility and inflammation are associated with alterations in the 425 
location, morphology or abundance of CD163+ve monocytes and macrophages 426 
changes, are therefore warranted.  427 
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Table 1. Horse details 443 
 Age (years) Sex Breed 
1 26 Gelding Thoroughbred cross 
2 21 Mare Thoroughbred cross 
3 10 Gelding Thoroughbred 
4 9 Gelding Irish type 
5 6 Gelding Thoroughbred 




7 19 Mare Thoroughbred cross 
8 15 Gelding Thoroughbred cross 
9 11 Gelding Shire 
10 21 Mare Sports horse 
 444 
Table 2. Description of anatomical locations used for tissue collection of the 445 
gastrointestinal tract 446 
GC = greater curvature; LC = lesser curvature 447 
 448 
ID # Location Description of location 
1 Stomach GC Greater curvature “at the greatest curve” 
2 Stomach LC Midpoint of lesser curvature on inside of curve 
3 Duodenum mid approx. 50-75cm from pylorus 
4 Jejunum proximal Full circumferential sample and then further 
samples cut from anti-mesenteric aspect 5 Jejunum mid 
6 Jejunum distal 
7 Ileum mid Ileum defined by ileocaecal fold, approx. 1m long. 
Midpoint ileum is midpoint of ileocaecal fold. 
Anti-mesenteric border. 
8 Caecum mid Sample taken 5cmaway from end of ileocaecal fold 
including taenial band 
9 Right ventral 
colon mid 





Figure 1. Distribution of CD163+ve macrophages in the equine 450 
gastrointestinal tract 451 
Floating box plots showing maximum, minimum and median cells per mm2  for 452 
each tissue layer (mucosa, submucosa, circular and longitudinal muscle, 453 
myenteric plexus and serosa) along the length of the equine gastrointestinal tract 454 
from (L-R); stomach lesser curvature (LC), stomach greater curvature(GC), 455 
duodenum, jejunum, ileum, caecum, right ventral colon (RVC), left ventral colon 456 
(LVC), pelvic flexure (PF), left dorsal colon (LDC), right dorsal colon (RDC) and 457 
small colon. n=10 458 
 459 
Figure 2. Comparison between cells /mm2 in the submucosa of the small 460 
intestine and large intestine. 461 
Floating box plot (minimum, maximum and median) showing individual values 462 
(black dots) of cells/mm2 in the submucosa of the small intestine (encompassiong 463 
regions from the stomach to the ileum) and the large intestine (encompassing 464 
10 Left ventral colon 
mid 
Midpoint over taenial band 
11 Pelvic flexure At apex from the anti-mesenteric aspect 
12 Left dorsal colon 
mid 
Midpoint on outer edge 
13 Right dorsal colon 
mid 
Midpoint on outer edge over taenial band 




regions from the caecum to the small colon). Difference in cells/mm2 as measured 465 
by a Mann–Whitney U test. ****p≤0.0001 466 
 467 
Figure 3. Lamina propria macrophages in the equine stomach, jejunum and 468 
right ventral colon 469 
Staining for CD163 using 3,3'-diaminobenzidine (DAB) as a chromogen in the 470 
mucosa of the equine stomach (A), jejunum (B) and right ventral colon (C). Red 471 
line represents basement membrane. Magnification X10. Bar=250µm. Images 472 
representative of samples taken from 10 horses. 473 
 474 
Figure 4 Morphology of lamina propria macrophages in the equine jejunum 475 
and right dorsal colon 476 
Staining for CD163 in the lamina propria of the equine jejunum (A) and right 477 
dorsal colon (B) using 3,3'-diaminobenzidine (DAB) as a chromogen with 478 
haematoxylin as a counterstain. (A) is a cross section. (B) is a whole mount. 479 
Yellow arrow = bipolar macrophage. Green arrow = macrophages with 3 or more 480 
ramifications. (A) and (B) X20 magnification Bar=100µm. Inset X80 Bar=25µm. 481 
Images representative of samples taken from 10 horses. 482 
 483 
Figure 5 Morphology of macrophages in the submucosa of the equine small 484 
intestine 485 
Staining for CD163 in the submucosa of the equine jejunum (A) and ileum (B) 486 




counterstain. Bipolar macrophages = green arrow, blue inset. Round macrophages 488 
= yellow arrow, red inset. (A) and (B) X20 magnification; Bar=100µm. Inset X80 489 
Bar=25µm. Images representative of samples taken from 10 horses. 490 
 491 
Figure 6 Morphology of macrophages in the submucosa of equine large 492 
intestine 493 
Staining for CD163 in the submucosa of the equine pelvic flexure (A) and left 494 
dorsal colon (B) using 3,3'-diaminobenzidine (DAB) as a chromogen with 495 
haematoxylin as a counterstain. Macrophages in the submucosa are predominantly 496 
round (red inset) with occasional bipolar cells (blue inset). 497 
(A) and (B) X20 magnification Bar=100µm. Inset X80 Bar=25µm. Images 498 
representative of samples taken from 10 horses. 499 
 500 
Figure 7 Macrophages in gut- associated lymphoid tissues in the equine large 501 
intestine 502 
Staining for CD163 in the equine right ventral colon using 3, 3’-diaminobenzidine 503 
(DAB) as a chromogen with haematoxylin as a counterstain. (A) X2.5 504 
magnification; Bar=1mm. Inset (B) X20 Bar=100µm. Images representative of 505 
samples taken from 5 horses. 506 
 507 




Staining for CD163 in the equine duodenum using 3, 3’-diaminobenzidine (DAB) 509 
as a chromogen with haematoxylin as a counterstain. (A) shows a low power field 510 
of view (X5 magnifiaction) of the muscularis externa (ME). CM, MP, LM and S 511 
represent high power view  (X 20 magnification) of circular muscle (CM), 512 
myenteric plexus (MP), longitudinal muscle (LM) and serosa (S).  (A) X5 513 
magnification Bar=500µm. (CM, MP, LM, S) X20 magnification  Bar=100µm. 514 
Images representative of samples taken from 10 horses. 515 
 516 
Figure 9 Serosal macrophages in the equine gastrointestinal tract 517 
Staining for CD163 in the serosa of the equine duodenum (A), ileum (B) and 518 
caecum (C) using 3, 3’-diaminobenzidine (DAB) as a chromogen with 519 
haematoxylin as a counterstain.  Magnification X40 magnification; Bar=50µm. 520 
Images representative of samples taken from 10 horses. 521 
 522 
Figure 10 Ramified macrophages in the serosa of equine left ventral colon 523 
Staining for CD163 in the serosa of equine left ventral colon using 3, 3’-524 
diaminobenzidine (DAB) as a chromogen with haematoxylin as a counterstain. 525 
Black arrow shows macrophage with ramified morphology. Magnification X40 526 
magnification. Bar=50µm. Image representative of samples taken from 5 horses. 527 
 528 
Figure 11 Muscularis macrophages in the equine ileum 529 
Staining for CD163 in the muscularis (circular muscle) of the equine ileum using 530 




counterstain. Macrophages were predominalty found between muscle bundles 532 
(black arrows) although occasional staining for CD163 was observed within a 533 
muscular bundle (red circle). Magnification X10. Bar=250µm. Image 534 
representative of small and large intestinal samples in 10 horses.  535 
 536 
Figure 12 Muscularis macrophages in equine duodenum 537 
Staining for CD163 in the muscularis (longitudinal layer) of the equine duodenum 538 
using 3, 3’-diaminobenzidine (DAB) as a chromogen with haematoxylin as a 539 
counterstain. Macrophages were observed between muscle bundles running 540 
longitudinally with the muscle (inset). Magnification X20. Bar=100µm. Inset 541 
X40. magnification. Bar=50µm Image representative of small and large intestinal 542 
samples in 10 horses.  543 
Figure 13 Morphology of intermuscular muscularis macrophages in equine 544 
ileum 545 
Staining for CD163 in the muscularis (circular muscle) of the equine ileum using 546 
3, 3’-diaminobenzidine (DAB) as a chromogen with haematoxylin as a 547 
counterstain. Macrophages were predominalty bipolar (black arrows) although 548 
occasional cicular cell bodies were observed (red circle). Magnification X40. 549 
Bar=50µm. Image representative of small and large intestinal samples in 10 550 
horses.  551 
 552 
Figure 14 Macrophages associated with the myenteric plexus in the equine 553 




Staining for CD163 in the myenteric plexus (MP) of the equine jejunum using 3, 555 
3’-diaminobenzidine (DAB) as a chromogen with haematoxylin as a counterstain. 556 
Macrophages were observed both on the edge of the MP (black arrows) and 557 
within the MP (red arrows). Magnification X40. Bar=50µm. CM, cricular muscle. 558 
LM, longitudinal muscle. Image representative of small and large intestinal 559 
samples in 10 horses.  560 
 561 
Figure 15 Morphology of myenteric plexus macrophages in the equine 562 
gastrointestinal tract 563 
Staining for CD163 in the myenteric plexus of the equine jejunum using 3, 3’-564 
diaminobenzidine (DAB) as a chromogen with haematoxylin as a counterstain. 565 
The morphology of myenteric plexus macrophages was either round (A) or 566 
ramified (B).  Magnification X80. Bar=25µm. Image representative of small and 567 
large intestinal samples in 10 horses.  568 
 569 
Figure 16 Comparison of cells/mm2 between the muscularis externa and 570 
myenteric plexus of the small and large intestine.  571 
Floating box plot (minimum, maximum and median) showing individual values 572 
(black dots) of cells/mm2 in the muscularis externa (circular muscle and 573 
longitudinal muscle) of the small intestine and the large intestine. Difference in 574 
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